Breast cancer adaptive resistance: HER2 and cancer stem cell repopulation in a heterogeneous tumor society

Author： Duru Nadire Candas Demet Jiang Guochun Li Jian

ISSN： 0171-5216

Source： Journal of Cancer Research and Clinical Oncology, Vol.140, Iss.1, 2014-01, pp. : 1-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

STAT3 activation in HER2-overexpressing breast cancer promotes epithelial-mesenchymal transition and cancer stem cell traits

International Journal of Oncology, Vol. 44, Iss. 2, 2014-01 ,pp. : 403-411

Spandidos Publications

Access to resources Recommend Favorite

EGFR over-expression and activation in high HER2, ER negative breast cancer cell line induces trastuzumab resistance

By Dua Rajiv

Breast Cancer Research and Treatment, Vol. 122, Iss. 3, 2010-08 ,pp. : 685-697

Springer Publishing Company

Access to resources Recommend Favorite

Mesenchymal stem cell-tumor cell cooperation in breast cancer vasculogenesis

Molecular Medicine Reports, Vol. 5, Iss. 5, 2012-01 ,pp. : 1175-1180

Spandidos Publications

Access to resources Recommend Favorite

Immunohistochemical determination of her2 expression in breast cancer from core biopsy specimens: a reliable predictor of her2 status of the whole tumor

By Mueller-Holzner E.

Breast Cancer Research and Treatment, Vol. 69, Iss. 1, 2001-09 ,pp. : 13-19

Springer Publishing Company

Access to resources Recommend Favorite

HER2 as a prognostic and predictive marker for breast cancer

By Cooke T. Reeves J. Lanigan A. Stanton P.

Annals of Oncology, Vol. 12, Iss. 12, 2001-12 ,pp. : 23-28

Springer Publishing Company

Access to resources Recommend Favorite